![Michael R. Goldberg](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Perfil
Michael R.
Goldberg joined Theravance, Inc. as Vice President of Clinical Pharmacology in September 2005.
From 1988 to 2005, he was Senior Director of Safety/Clinical Risk Management and Safety Surveillance for Merck and worked at Eli Lilly in the Clinical Pharmacology Department.
Dr. Goldberg received his MD and PhD degrees from Tulane University, School of Medicine and completed his Clinical Pharmacology fellowship at the Vanderbilt University School of Medicine.
Antiguos cargos conocidos de Michael R. Goldberg.
| Empresas | Cargo | Fin |
|---|---|---|
| MERCK & CO., INC. | Corporate Officer/Principal | 01/01/2005 |
| INNOVIVA, INC. | Corporate Officer/Principal | - |
Formación de Michael R. Goldberg.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
97
Relaciones de 1er grado
3
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 3 |
|---|---|
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Innoviva, Inc.
 Innoviva, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that manufactures respiratory drugs | Health Technology |
Tulane University (Louisiana)
 Tulane University (Louisiana) Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
- Bolsa de valores
- Insiders
- Michael R. Goldberg
